The study population of this analysis consists of the 1,034,270 patients that had contact with the US healthcare system for a diagnosis of CLD, 16,530 patients with COVID-19 and 820 people with COVID-19 and CLD. According to the CDC and American Association for the Study of Liver Diseases, people with CLD may be at increased risk for getting COVID-19. As a result this study was done focusing on three things. The first part of the study was to compare the odds of COVID-19 diagnosis in patients with CLD to those without CLD adjusted for race, age, gender and other known COVID-19 comorbidities and risk factors. Next was to see how age, gender and race further impacted the COVID-19 risk for those with CLD. For example case groups of patients with CLD that are female, over 65 or African American were studies with comparison groups that were male, under 65 or Caucasian. The last part of this study was to compare death rates and hospitalizations for COVID-19 patients with no CLD and recent CLD encounters over the span on 8 months.